Erik Harms
Muenster, NW 48149, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients.
Journal: Pharmaceutics
Published: June 01, 2023
Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study.
Journal: Journal of inherited metabolic disease
Published: August 02, 2022
Neuromuscular conditions and the impact of cystine-depleting therapy in infantile nephropathic cystinosis: A cross-sectional analysis of 55 patients.
Journal: Journal of inherited metabolic disease
Published: August 25, 2021
A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis.
Journal: Orphanet journal of rare diseases
Published: June 03, 2021
Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years.
Journal: Orphanet journal of rare diseases
Published: December 09, 2020
Cystinosis: Therapy adherence and metabolic monitoring in patients treated with immediate-release cysteamine.
Journal: Molecular genetics and metabolism reports
Published: June 20, 2020
One Year of Newborn Screening for SMA - Results of a German Pilot Project.
Journal: Journal of neuromuscular diseases
Published: October 09, 2019
Molecular based newborn screening in Germany: Follow-up for cystinosis.
Journal: Molecular genetics and metabolism reports
Published: August 17, 2019
Management of bone disease in cystinosis: Statement from an international conference.
Journal: Journal of inherited metabolic disease
Published: April 25, 2019
Next generation sequencing as second-tier test in high-throughput newborn screening for nephropathic cystinosis.
Journal: European journal of human genetics : EJHG
Published: April 02, 2019
Spinal muscular atrophy : Time for newborn screening?
Journal: Der Nervenarzt
Published: November 05, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026